 | • レポートコード：GIR-2104Z11897 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、研究用抗体のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。研究用抗体の種類別市場規模（モノクローナル抗体、ポリクローナル抗体）、用途別市場規模（学術研究機関、委託研究機関、製薬・バイオテクノロジー産業）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・研究用抗体の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abcam PLC、Agilent Technologies、Thermo Fisher Scientific, Inc.、Bio - Rad Laboratories、Merck Millipore (Danaher)、Lonza Group、F.Hoffmann La Roche Ltd.、Cell Signalling Technology, Inc.、PerkinElmer, Inc. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：モノクローナル抗体、ポリクローナル抗体 ・用途別分析2016年-2026年：学術研究機関、委託研究機関、製薬・バイオテクノロジー産業 ・研究用抗体の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・研究用抗体のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・研究用抗体のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・研究用抗体の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・研究用抗体の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Research Antibodies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Research Antibodies size is estimated to be USD 9979.6 million in 2025 from USD 8742.5 million in 2019, with a change XX% between 2019 and 2020. The global Research Antibodies market size is expected to grow at a CAGR of 3.4% for the next five years.
Market segmentation
Research Antibodies market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Monoclonal Antibodies
Polyclonal Antibodies
Market segment by Application, can be divided into
Academic & Research Institutes
Contract Research Organizations
Pharmaceutical & Biotechnology Companies
Market segment by players, this report covers
Abcam PLC
Agilent Technologies
Thermo Fisher Scientific, Inc.
Bio – Rad Laboratories
Merck Millipore (Danaher)
Lonza Group
F.Hoffmann La Roche Ltd.
Cell Signalling Technology, Inc.
PerkinElmer, Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Research Antibodies
1.2 Classification of Research Antibodies by Type
1.2.1 Overview: Global Research Antibodies Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Research Antibodies Revenue Market Share by Type in 2020
1.2.3 Monoclonal Antibodies
1.2.4 Polyclonal Antibodies
1.3 Global Research Antibodies Market by Application
1.3.1 Overview: Global Research Antibodies Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Academic & Research Institutes
1.3.3 Contract Research Organizations
1.3.4 Pharmaceutical & Biotechnology Companies
1.4 Global Research Antibodies Market Size & Forecast
1.5 Global Research Antibodies Market Size and Forecast by Region
1.5.1 Global Research Antibodies Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Research Antibodies Market Size by Region, (2016-2021)
1.5.3 North America Research Antibodies Market Size and Prospect (2016-2026)
1.5.4 Europe Research Antibodies Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Research Antibodies Market Size and Prospect (2016-2026)
1.5.6 South America Research Antibodies Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Research Antibodies Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Research Antibodies Market Drivers
1.6.2 Research Antibodies Market Restraints
1.6.3 Research Antibodies Trends Analysis
2 Company Profiles
2.1 Abcam PLC
2.1.1 Abcam PLC Details
2.1.2 Abcam PLC Major Business
2.1.3 Abcam PLC Research Antibodies Product and Solutions
2.1.4 Abcam PLC Research Antibodies Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Abcam PLC Recent Developments and Future Plans
2.2 Agilent Technologies
2.2.1 Agilent Technologies Details
2.2.2 Agilent Technologies Major Business
2.2.3 Agilent Technologies Research Antibodies Product and Solutions
2.2.4 Agilent Technologies Research Antibodies Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Agilent Technologies Recent Developments and Future Plans
2.3 Thermo Fisher Scientific, Inc.
2.3.1 Thermo Fisher Scientific, Inc. Details
2.3.2 Thermo Fisher Scientific, Inc. Major Business
2.3.3 Thermo Fisher Scientific, Inc. Research Antibodies Product and Solutions
2.3.4 Thermo Fisher Scientific, Inc. Research Antibodies Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
2.4 Bio – Rad Laboratories
2.4.1 Bio – Rad Laboratories Details
2.4.2 Bio – Rad Laboratories Major Business
2.4.3 Bio – Rad Laboratories Research Antibodies Product and Solutions
2.4.4 Bio – Rad Laboratories Research Antibodies Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Bio – Rad Laboratories Recent Developments and Future Plans
2.5 Merck Millipore (Danaher)
2.5.1 Merck Millipore (Danaher) Details
2.5.2 Merck Millipore (Danaher) Major Business
2.5.3 Merck Millipore (Danaher) Research Antibodies Product and Solutions
2.5.4 Merck Millipore (Danaher) Research Antibodies Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Merck Millipore (Danaher) Recent Developments and Future Plans
2.6 Lonza Group
2.6.1 Lonza Group Details
2.6.2 Lonza Group Major Business
2.6.3 Lonza Group Research Antibodies Product and Solutions
2.6.4 Lonza Group Research Antibodies Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Lonza Group Recent Developments and Future Plans
2.7 F.Hoffmann La Roche Ltd.
2.7.1 F.Hoffmann La Roche Ltd. Details
2.7.2 F.Hoffmann La Roche Ltd. Major Business
2.7.3 F.Hoffmann La Roche Ltd. Research Antibodies Product and Solutions
2.7.4 F.Hoffmann La Roche Ltd. Research Antibodies Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 F.Hoffmann La Roche Ltd. Recent Developments and Future Plans
2.8 Cell Signalling Technology, Inc.
2.8.1 Cell Signalling Technology, Inc. Details
2.8.2 Cell Signalling Technology, Inc. Major Business
2.8.3 Cell Signalling Technology, Inc. Research Antibodies Product and Solutions
2.8.4 Cell Signalling Technology, Inc. Research Antibodies Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Cell Signalling Technology, Inc. Recent Developments and Future Plans
2.9 PerkinElmer, Inc.
2.9.1 PerkinElmer, Inc. Details
2.9.2 PerkinElmer, Inc. Major Business
2.9.3 PerkinElmer, Inc. Research Antibodies Product and Solutions
2.9.4 PerkinElmer, Inc. Research Antibodies Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 PerkinElmer, Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Research Antibodies Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Research Antibodies Players Market Share
3.2.2 Top 10 Research Antibodies Players Market Share
3.2.3 Market Competition Trend
3.3 Research Antibodies Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Research Antibodies Revenue and Market Share by Type (2016-2021)
4.2 Global Research Antibodies Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Research Antibodies Revenue Market Share by Application (2016-2021)
5.2 Research Antibodies Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Research Antibodies Revenue by Type (2016-2026)
6.2 North America Research Antibodies Revenue by Application (2016-2026)
6.3 North America Research Antibodies Market Size by Country
6.3.1 North America Research Antibodies Revenue by Country (2016-2026)
6.3.2 United States Research Antibodies Market Size and Forecast (2016-2026)
6.3.3 Canada Research Antibodies Market Size and Forecast (2016-2026)
6.3.4 Mexico Research Antibodies Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Research Antibodies Revenue by Type (2016-2026)
7.2 Europe Research Antibodies Revenue by Application (2016-2026)
7.3 Europe Research Antibodies Market Size by Country
7.3.1 Europe Research Antibodies Revenue by Country (2016-2026)
7.3.2 Germany Research Antibodies Market Size and Forecast (2016-2026)
7.3.3 France Research Antibodies Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Research Antibodies Market Size and Forecast (2016-2026)
7.3.5 Russia Research Antibodies Market Size and Forecast (2016-2026)
7.3.6 Italy Research Antibodies Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Research Antibodies Revenue by Type (2016-2026)
8.2 Asia-Pacific Research Antibodies Revenue by Application (2016-2026)
8.3 Asia-Pacific Research Antibodies Market Size by Region
8.3.1 Asia-Pacific Research Antibodies Revenue by Region (2016-2026)
8.3.2 China Research Antibodies Market Size and Forecast (2016-2026)
8.3.3 Japan Research Antibodies Market Size and Forecast (2016-2026)
8.3.4 South Korea Research Antibodies Market Size and Forecast (2016-2026)
8.3.5 India Research Antibodies Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Research Antibodies Market Size and Forecast (2016-2026)
8.3.7 Australia Research Antibodies Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Research Antibodies Revenue by Type (2016-2026)
9.2 South America Research Antibodies Revenue by Application (2016-2026)
9.3 South America Research Antibodies Market Size by Country
9.3.1 South America Research Antibodies Revenue by Country (2016-2026)
9.3.2 Brazil Research Antibodies Market Size and Forecast (2016-2026)
9.3.3 Argentina Research Antibodies Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Research Antibodies Revenue by Type (2016-2026)
10.2 Middle East & Africa Research Antibodies Revenue by Application (2016-2026)
10.3 Middle East & Africa Research Antibodies Market Size by Country
10.3.1 Middle East & Africa Research Antibodies Revenue by Country (2016-2026)
10.3.2 Turkey Research Antibodies Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Research Antibodies Market Size and Forecast (2016-2026)
10.3.4 UAE Research Antibodies Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Research Antibodies Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Research Antibodies Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Research Antibodies Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Research Antibodies Revenue (USD Million) by Region (2016-2021)
Table 5. Global Research Antibodies Revenue Market Share by Region (2021-2026)
Table 6. Abcam PLC Corporate Information, Head Office, and Major Competitors
Table 7. Abcam PLC Major Business
Table 8. Abcam PLC Research Antibodies Product and Solutions
Table 9. Abcam PLC Research Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Agilent Technologies Corporate Information, Head Office, and Major Competitors
Table 11. Agilent Technologies Major Business
Table 12. Agilent Technologies Research Antibodies Product and Solutions
Table 13. Agilent Technologies Research Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Thermo Fisher Scientific, Inc. Corporate Information, Head Office, and Major Competitors
Table 15. Thermo Fisher Scientific, Inc. Major Business
Table 16. Thermo Fisher Scientific, Inc. Research Antibodies Product and Solutions
Table 17. Thermo Fisher Scientific, Inc. Research Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Bio - Rad Laboratories Corporate Information, Head Office, and Major Competitors
Table 19. Bio - Rad Laboratories Major Business
Table 20. Bio - Rad Laboratories Research Antibodies Product and Solutions
Table 21. Bio - Rad Laboratories Research Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Merck Millipore (Danaher) Corporate Information, Head Office, and Major Competitors
Table 23. Merck Millipore (Danaher) Major Business
Table 24. Merck Millipore (Danaher) Research Antibodies Product and Solutions
Table 25. Merck Millipore (Danaher) Research Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Lonza Group Corporate Information, Head Office, and Major Competitors
Table 27. Lonza Group Major Business
Table 28. Lonza Group Research Antibodies Product and Solutions
Table 29. Lonza Group Research Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. F.Hoffmann La Roche Ltd. Corporate Information, Head Office, and Major Competitors
Table 31. F.Hoffmann La Roche Ltd. Major Business
Table 32. F.Hoffmann La Roche Ltd. Research Antibodies Product and Solutions
Table 33. F.Hoffmann La Roche Ltd. Research Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Cell Signalling Technology, Inc. Corporate Information, Head Office, and Major Competitors
Table 35. Cell Signalling Technology, Inc. Major Business
Table 36. Cell Signalling Technology, Inc. Research Antibodies Product and Solutions
Table 37. Cell Signalling Technology, Inc. Research Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. PerkinElmer, Inc. Corporate Information, Head Office, and Major Competitors
Table 39. PerkinElmer, Inc. Major Business
Table 40. PerkinElmer, Inc. Research Antibodies Product and Solutions
Table 41. PerkinElmer, Inc. Research Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Research Antibodies Revenue (USD Million) by Players (2019-2021)
Table 43. Global Research Antibodies Revenue Share by Players (2019-2021)
Table 44. Breakdown of Research Antibodies by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Research Antibodies Players Head Office, Products and Services Provided
Table 46. Research Antibodies Mergers & Acquisitions in the Past Five Years
Table 47. Research Antibodies New Entrants and Expansion Plans
Table 48. Global Research Antibodies Revenue (USD Million) by Type (2016-2021)
Table 49. Global Research Antibodies Revenue Share by Type (2016-2021)
Table 50. Global Research Antibodies Revenue Forecast by Type (2021-2026)
Table 51. Global Research Antibodies Revenue by Application (2016-2021)
Table 52. Global Research Antibodies Revenue Forecast by Application (2021-2026)
Table 53. North America Research Antibodies Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Research Antibodies Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Research Antibodies Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Research Antibodies Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Research Antibodies Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Research Antibodies Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Research Antibodies Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Research Antibodies Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Research Antibodies Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Research Antibodies Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Research Antibodies Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Research Antibodies Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Research Antibodies Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Research Antibodies Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Research Antibodies Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Research Antibodies Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Research Antibodies Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Research Antibodies Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Research Antibodies Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Research Antibodies Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Research Antibodies Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Research Antibodies Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Research Antibodies Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Research Antibodies Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Research Antibodies Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Research Antibodies Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Research Antibodies Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Research Antibodies Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Research Antibodies Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Research Antibodies Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Research Antibodies Picture
Figure 2. Global Research Antibodies Revenue Market Share by Type in 2020
Figure 3. Monoclonal Antibodies
Figure 4. Polyclonal Antibodies
Figure 5. Research Antibodies Revenue Market Share by Application in 2020
Figure 6. Academic & Research Institutes Picture
Figure 7. Contract Research Organizations Picture
Figure 8. Pharmaceutical & Biotechnology Companies Picture
Figure 9. Global Research Antibodies Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 10. Global Research Antibodies Revenue and Forecast (2016-2026) & (USD Million)
Figure 11. Global Research Antibodies Revenue Market Share by Region (2016-2026)
Figure 12. Global Research Antibodies Revenue Market Share by Region in 2020
Figure 13. North America Research Antibodies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 14. Europe Research Antibodies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Asia-Pacific Research Antibodies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. South America Research Antibodies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Research Antibodies Market Drivers
Figure 18. Research Antibodies Market Restraints
Figure 19. Research Antibodies Market Trends
Figure 20. Abcam PLC Recent Developments and Future Plans
Figure 21. Agilent Technologies Recent Developments and Future Plans
Figure 22. Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
Figure 23. Bio - Rad Laboratories Recent Developments and Future Plans
Figure 24. Merck Millipore (Danaher) Recent Developments and Future Plans
Figure 25. Lonza Group Recent Developments and Future Plans
Figure 26. F.Hoffmann La Roche Ltd. Recent Developments and Future Plans
Figure 27. Cell Signalling Technology, Inc. Recent Developments and Future Plans
Figure 28. PerkinElmer, Inc. Recent Developments and Future Plans
Figure 30. Global Research Antibodies Revenue Share by Players in 2020
Figure 31. Research Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 32. Global Top 3 Players Research Antibodies Revenue Market Share in 2020
Figure 33. Global Top 10 Players Research Antibodies Revenue Market Share in 2020
Figure 34. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 35. Global Research Antibodies Revenue Share by Type in 2020
Figure 36. Global Research Antibodies Market Share Forecast by Type (2021-2026)
Figure 37. Global Research Antibodies Revenue Share by Application in 2020
Figure 38. Global Research Antibodies Market Share Forecast by Application (2021-2026)
Figure 39. North America Research Antibodies Sales Market Share by Type (2016-2026)
Figure 40. North America Research Antibodies Sales Market Share by Application (2016-2026)
Figure 41. North America Research Antibodies Revenue Market Share by Country (2016-2026)
Figure 42. United States Research Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Canada Research Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Mexico Research Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Europe Research Antibodies Sales Market Share by Type (2016-2026)
Figure 46. Europe Research Antibodies Sales Market Share by Application (2016-2026)
Figure 47. Europe Research Antibodies Revenue Market Share by Country (2016-2026)
Figure 48. Germany Research Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France Research Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom Research Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia Research Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy Research Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific Research Antibodies Sales Market Share by Type (2016-2026)
Figure 54. Asia-Pacific Research Antibodies Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific Research Antibodies Revenue Market Share by Region (2016-2026)
Figure 56. China Research Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Research Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. South Korea Research Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Research Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Research Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Research Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Research Antibodies Sales Market Share by Type (2016-2026)
Figure 63. South America Research Antibodies Sales Market Share by Application (2016-2026)
Figure 64. South America Research Antibodies Revenue Market Share by Country (2016-2026)
Figure 65. Brazil Research Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Argentina Research Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Middle East and Africa Research Antibodies Sales Market Share by Type (2016-2026)
Figure 68. Middle East and Africa Research Antibodies Sales Market Share by Application (2016-2026)
Figure 69. Middle East and Africa Research Antibodies Revenue Market Share by Country (2016-2026)
Figure 70. Turkey Research Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Saudi Arabia Research Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. UAE Research Antibodies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Methodology
Figure 74. Research Process and Data Source
世界のCD38モノクローナル抗体市場規模・現状・予測（2021年-2027年） CD38 monoclonal antibodies target the CD38 surface antigen(sAg) of hematopoietic cells, which is important for cell function. Once CD38 monoclonal antibodies bind to the antigen it inhibits tumour growth by interrupting CD38 functions and causes cell death. CD38 monoclonal antibodies are used to tre…- 世界のIGYポリクローナル抗体市場規模・現状・予測（2021年-2027年） Immunoglobulin Y (abbreviated as IgY) is a type of immunoglobulin which is the major antibody in bird, reptile, and lungfish blood. It is also found in high concentrations in chicken egg yolk. As with the other immunoglobulins, IgY is a class of proteins which are formed by the immune system in reac…
- 世界の診断用特殊抗体市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Diagnostic Specialty Antibodies Market The global Diagnostic Specialty Antibodies market size is projected to reach US$ 24780 million by 2026, from US$ 20090 million in 2019, at a CAGR of 3.0% during 2021-2026. With industry-standard accuracy in analysis and high…
- 世界の診断用特殊抗体市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Diagnostic Specialty Antibodies Market The global Diagnostic Specialty Antibodies market size is projected to reach US$ 24780 million by 2026, from US$ 20090 million in 2019, at a CAGR of 3.0% during 2021-2026. With industry-standard accuracy in analysis and high…
- 世界のHER2抗体市場規模・現状・予測（2021年-2027年） The demand of HER2 Antibodies is increasing, and primarily gaining from growing awareness regarding the prevalence of HER2 positive breast cancer. Market Analysis and Insights: Global HER2 Antibodies Market The global HER2 Antibodies market size is projected to reach US$ 11440 million by 2026, from …